ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02094261
Brief Title: Phase II AZD9291 Open Label Study in NSCLC After Previous EGFR TKI Therapy in EGFR and T790M Mutation Positive Tumours (AURA2)

First Submitted : March 17, 2014
First Submitted that Met QC Criteria : March 20, 2014
First Posted : March 21, 2014 (Estimate)

Results First Submitted : April 28, 2016
Results First Submitted that Met QC Criteria : April 28, 2016
Results First Posted : June 7, 2016 (Estimate)

Last Update Submitted that Met QC Criteria : December 13, 2018
Last Update Posted : December 14, 2018